UBC is playing a key role in understanding and preventing chronic diseases like diabetes and arthritis. With a commitment to evidence-based practice, our researchers are generating new knowledge that is reshaping how we treat and manage complex diseases.
Spotlight
New study to explore potential of magnetic nanoparticles to help treat type 2 diabetes
The two-year project is funded by the Government of Canada’s New Frontiers in Research Fund.
A baby’s first poop can help predict risk of developing allergies
The study findings have important implications for at-risk infants.
Scientists discover key enzyme responsible for skin blistering in the elderly
Research identifies a novel treatment for the most common autoimmune blistering diseases.
Peanut allergy treatment significantly lowers risk of life-threatening reactions in preschoolers
After one year of treatment, nearly 80 per cent of study participants could eat 15 peanuts without a reaction
Research could change how blood pressure is managed in spinal cord injury patients
The study findings challenge the current standard.
Spinal cord injury research at UBC receives $48M grant
The five-year project will revolutionize spinal cord injury treatments using innovative, implantable technologies.
Falling childhood asthma rates linked to declining use of unnecessary antibiotics
A new study suggests that careful antibiotic use in children under the age of one is important to help preserve the diversity and abundance of healthy gut bacteria.
Researchers uncover novel approach for treating eczema
Approximately 15-20 per cent of Canadians live with some form of eczema
UBC researchers seek participants for spinal cord injury study
Dr. Andrei Krassioukov explains the purpose of the study and how eligible patients can get involved.
Specialized immune cells could help repair damage from inflammatory bowel disease in children
A type of T cell produces a chemical signal that helps repair the barrier formed by cells lining the gut.